Guggenheim Capital LLC Qiagen N.V. Transaction History

Guggenheim Capital LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$43.93 - $46.76 $280,800 - $298,889	6,392 New	6,392 $287,000
Q4 2021 Feb 14, 2022	SELL	$50.62 - $56.47 $331,561 - $369,878	-6,550 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$46.55 - $56.83 $24,392 - $29,778	524 Added 8.7%	6,550 $339,000
Q2 2021 Aug 13, 2021	BUY	$46.28 - $52.75 $26,796 - $30,542	579 Added 10.63%	6,026 $292,000
Q1 2021 May 13, 2021	SELL	$46.25 - $56.02 $54,158 - $65,599	-1,171 Reduced 17.69%	5,447 $265,000
Q4 2020 Feb 16, 2021	BUY	$46.09 - $54.74 $305,023 - $362,269	6,618 New	6,618 $350,000
Q2 2018 Aug 14, 2018	SELL	$31.23 - $37.47 $5.94 Million - $7.13 Million	-190,177 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$31.01 - $34.72 $1.74 Million - $1.95 Million	56,228 Added 41.98%	190,177 $6.15 Million
Q4 2017 Feb 14, 2018	SELL	$30.68 - $35.37 $234,211 - $270,014	-7,634 Reduced 5.39%	133,949 $4.14 Million
Q3 2017 Nov 14, 2017	BUY	$31.02 - $32.94 $4.39 Million - $4.66 Million	141,583	141,583 $4.46 Million

6.34M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $10.2B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.